Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...
Bone Pain in Paediatric IBD: A Rare but Important Link In children with inflammatory bowel disease, persistent bone pain may signal chronic non-bacterial osteomyelitis, a rare association that ...
Ulcerative colitis is a chronic condition that affects the large intestines, particularly the colon. It is classified as one of the two inflammatory bowel diseases along with Crohn’s disease. Loss of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results